Verrucous hemangioma: A report of two cases and review of the literature

Journal of Cutaneous Pathology

Volumn 38, Issue 9, 2011, Pages 740-746

  Clairwood, Marimeg Q ^a   Bruckner, Anna L ^b   Dadras, Soheil S ^c  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

angiokeratoma; Prox1; vascular malformation; vascular tumor; verrucous hemangioma

Indexed keywords

CASE REPORT; CHILD; DERMIS; HEMANGIOMA; HUMAN; MALE; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; REVIEW; SKIN TUMOR; VERRUCOUS CARCINOMA;

CARCINOMA, VERRUCOUS; CHILD; CHILD, PRESCHOOL; DERMIS; HEMANGIOMA; HUMANS; MALE; SKIN NEOPLASMS;

EID: 79960846856     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01733.x     Document Type: Article

References (30)

1. Imperial R, Helwig EB., Verrucous hemangioma. A clinicopathologic study of 21 cases. Arch Dermatol 1967; 96: 247.
2. Hayashi H, Shimizu T, Nakamura H, Shimizu H., Linear verrucous haemangioma on the abdomen. Acta Derm Venereol 2004; 84: 79.
3. Wentscher U, Happle R., Linear verrucous hemangioma. J Am Acad Dermatol 2000; 42: 516.
4. Akyol I, Jayanthi VR, Luquette MH., Verrucous hemangioma of the glans penis. Urology 2008; 72: 230.e15.
5. Yang CH, Ohara K., Successful surgical treatment of verrucous hemangioma: a combined approach. Dermatol Surg 2002; 28: 913.
6. Mankani MH, Dufresne CR., Verrucous malformations: their presentation and management. Ann Plast Surg 2000; 45: 31.
7. Tennant LB, Mulliken JB, Perez-Atayde AR, Kozakewich HP., Verrucous hemangioma revisited. Pediatr Dermatol 2006; 23: 208.
8. Koc M, Kavala M, Kocaturk E, et al., An unusual vascular tumor: verrucous hemangioma. Dermatol Online J 2009; 15: 7.
9. Pelletier J, Bruening W, Kashtan CE, et al., Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991; 67: 437.
10. Call KM, Glaser T, Ito CY, et al., Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60: 509.
11. Lawley LP, Cerimele F, Weiss SW, et al., Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. Archives of dermatology 2005; 141: 1297.
12. Al Dhaybi R, Powell J, McCuaig C, Kokta V., Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases. J Am Acad Dermatol 2010; 63: 1052.
13. North PE, Waner M, Mizeracki A, Mihm MC Jr. , GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31: 11.
14. Marks A, Sutherland DR, Bailey D, et al., Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 1999; 80: 569.
15. Schacht V, Dadras SS, Johnson L, Jackson D, Hong YK, Detmar M., Upregulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005; 166: 913.
16. Debelenko LV, Perez-Atayde AR, Mulliken JB, Liang MG, Archibald TH, Kozakewich HP., D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol 2005; 18: 1454.
17. Wigle JT, Oliver G., Prox1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769.
18. Le Huu AR, Jokinen CH, Ruben BP, et al., Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol 2010; 34: 1563.
19. Wilting J, Papoutsi M, Christ B, et al., The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002; 7: 7.
20. Rossi A, Bozzi M, Barra E., Verrucous hemangioma and angiokeratoma circumscriptum: clinical and histologic differential characteristics. J Dermatol Surg Oncol 1989; 15: 88.
21. Dadras SS, Detmar M., Angiogenesis and lymphangiogenesis of skin cancers. Hematol Oncol Clin North Am 2004; 18: 1059.
22. Hatva E, Kaipainen A, Mentula P, et al., Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 1995; 146: 368.
23. Banerji S, Ni J, Wang SX, et al., LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144: 789.
24. Breiteneder-Geleff S, Matsui K, Soleiman A, et al., Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 1997; 151: 1141.
25. Wigle JT, Chowdhury K, Gruss P, Oliver G., Prox1 function is crucial for mouse lens-fibre elongation. Nat Genet 1999; 21: 318.
26. Folpe AL, Veikkola T, Valtola R, Weiss SW., Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 2000; 13: 180.
27. Galambos C, Nodit L., Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Pediatr Dev Pathol 2005; 8: 181.
28. Arai E, Kuramochi A, Tsuchida T, et al., Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma. J Cutan Pathol 2006; 33: 492.
29. Hong Y-K, Harvey N, Noh Y-H, et al., Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 2002; 225: 351.
30. Petrova TV, Maekinen T, Maekelae TP, et al., Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 2002; 21: 4593.